Metabolic responsive factors in cardiovascular disease
Metabolic responsive factors in cardiovascular disease
批准号:
7576816
负责人:
RICHARD M MORTENSEN
金额:
$36.9万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-03-01 至 2011-02-28
关键词:
2,4-thiazolidinedioneAgonistAnimalsAnti-Inflammatory AgentsAnti-inflammatoryAntidiabetic DrugsBlood PressureBlood VesselsCardiacCardiac MyocytesCardiovascular DiseasesCardiovascular systemCell LineCell NucleusCell SurvivalCellsChromosomesComplexCytoplasmDataDependencyDiabetes MellitusDisease modelEmbryoEndothelial CellsFibrosisGenesGlucoseGoalsGrowthHeart HypertrophyHumanHypertensionHypertrophyImmunoprecipitationInflammationInsulin ResistanceKnock-outLipidsMAP Kinase GeneMediatingMediator of activation proteinMetabolicMetabolic DiseasesMineralocorticoid ReceptorMolecularMuscle functionMutationMyocardiumPathologicPathway interactionsPeroxisome Proliferator-Activated ReceptorsPhenotypePhosphotransferasesPhysiologicalPlayPositioning AttributeRegulationReportingResearch PersonnelResponse ElementsRoleSmooth MuscleSmooth Muscle MyocytesStressTANK-binding kinase 1TestingThiazolidinedionesTissuesTranscription CoactivatorVascular Endotheliumbasecardiovascular risk factorcell growthcell typediabeticin vivointerdisciplinary approachknockout animalknockout genelipid biosynthesisnovelpressureresponsetranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PPAR^/, a major target for the antidiabetic thiazolidinediones (TZDs), is a transcription factor that
occupies a position integrating metabolic and cardiovascular responses. PPAR-y is critical for adipogenesis
and mutations in PPAR-y have been shown to cause insulin resistance, diabetes and hypertension. TZDs
have recently been shown to alter blood pressure in animals and humans and to modify vascular endothelial
and smooth muscle function. Therefore, PPAR-y is likely candidate for mediating the interface between
metabolic disease and cardiovascular disease. However, it is unclear if PPAR-y in vascular tissues is critical
to in vivo responses and whether TZD effects on vascular function are mediated by PPAR-y. Our goal is to
determine the role of PPAR--y in cardiac and vascular cells and to determine its role in mediating the
associations of metabolic and cardiovascular diseases.
This proposal will answer three critical questions. What is the physiologic function of PPAR-y in the
cardiovascular system in otherwise normal animals? What is the role of PPAR-y in pathologic disease
models? Finally, what are the mechanisms of PPAR-y and TZD effects (i.e. what TZD effects mediated by
PPAR-y and what are the molecular mechanisms?)? To answer these questions, we have produced a novel
"whole body" PPAR-y knockout, cardiomyocyte and endothelial cell-type restricted knockouts and propose
smooth muscle cell knockouts. We will use a multidisciplinary approach, focused on these gene knockouts,
to determine the physiologic role and mechanisms of action of the cardiovascular PPAR-y. By determining
the phenotype of these knockout animals we anticipate defining the role of PPAR-y in cardiovascular tissue.
Therefore, we will be able to determine if PPAR-y mediates TZD effects. Based on our preliminary data, we
will test the hypothesis that PPAR-y is critical to normal regulation of cardiovascular cell growth, protects
cells from diabetic glucolipotoxicity and regulates blood pressure (likely predominately in the endothelial
cell)-All in a physiologic important context..
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.bbrc.2012.05.041
发表时间:
2012-06-15
期刊:
Biochemical and biophysical research communications
影响因子:
3.1
作者:
[Shen Z, Li C, Frieler RA, Gerasimova AS, Lee SJ, Wu J, Wang MM, Lumeng CN, Brosius FC 3rd, Duan SZ, Mortensen RM]
通讯作者:
Mortensen RM
Myeloid reprogramming in cardiac protection by aldosterone antagonists
-
批准号:8632091
-
项目类别:
-
资助金额:$38.26万
-
财政年份:2014
-
负责人:RICHARD M MORTENSEN
-
依托单位:
Myeloid Reprogramming in Cardiac Protection by Aldosterone Antagonists
-
批准号:9338941
-
项目类别:
-
资助金额:$8.56万
-
财政年份:2014
-
负责人:RICHARD M MORTENSEN
-
依托单位:
Myeloid reprogramming in cardiac protection by aldosterone antagonists
-
批准号:9206515
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2014
-
负责人:RICHARD M MORTENSEN
-
依托单位:
Metabolic responsive factors in cardiovascular disease
-
批准号:7189906
-
项目类别:
-
资助金额:$36.9万
-
财政年份:2006
-
负责人:RICHARD M MORTENSEN
-
依托单位:
Metabolic responsive factors in cardiovascular disease
-
批准号:7021909
-
项目类别:
-
资助金额:$38.08万
-
财政年份:2006
-
负责人:RICHARD M MORTENSEN
-
依托单位:
Metabolic responsive factors in cardiovascular disease
-
批准号:7371116
-
项目类别:
-
资助金额:$36.9万
-
财政年份:2006
-
负责人:RICHARD M MORTENSEN
-
依托单位:
New G-Protein Signaling Pathways
-
批准号:6783423
-
项目类别:
-
资助金额:$33.49万
-
财政年份:2003
-
负责人:RICHARD M MORTENSEN
-
依托单位:
New G-Protein Signaling Pathways
-
批准号:6619040
-
项目类别:
-
资助金额:$33.49万
-
财政年份:2003
-
负责人:RICHARD M MORTENSEN
-
依托单位:
New G-Protein Signaling Pathways
-
批准号:7095995
-
项目类别:
-
资助金额:$32.5万
-
财政年份:2003
-
负责人:RICHARD M MORTENSEN
-
依托单位:
New G-Protein Signaling Pathways
-
批准号:6925514
-
项目类别:
-
资助金额:$33.47万
-
财政年份:2003
-
负责人:RICHARD M MORTENSEN
-
依托单位:
MUSCARINIC AND ADENOSINE RECEPTOR SIGNAL TRANSDUCTION
-
批准号:2636870
-
项目类别:
-
资助金额:$28.59万
-
财政年份:1998
-
负责人:RICHARD M MORTENSEN
-
依托单位:
MUSCARINIC AND ADENOSINE RECEPTOR SIGNAL TRANSDUCTION
-
批准号:6184127
-
项目类别:
-
资助金额:$4.75万
-
财政年份:1998
-
负责人:RICHARD M MORTENSEN
-
依托单位:
MUSCARINIC AND ADENOSINE RECEPTOR SIGNAL TRANSDUCTION
-
批准号:2901321
-
项目类别:
-
资助金额:$31.01万
-
财政年份:1998
-
负责人:RICHARD M MORTENSEN
-
依托单位:
MUSCARINIC AND ADENOSINE RECEPTOR SIGNAL TRANSDUCTION
-
批准号:6344315
-
项目类别:
-
资助金额:$27.19万
-
财政年份:1998
-
负责人:RICHARD M MORTENSEN
-
依托单位:
MUSCARINIC AND ADENOSINE RECEPTOR SIGNAL TRANSDUCTION
-
批准号:6389701
-
项目类别:
-
资助金额:$29.78万
-
财政年份:1998
-
负责人:RICHARD M MORTENSEN
-
依托单位:
STRUCTURE-FUNCTION ANALYSIS OF G PROTEIN SUBUNITS
-
批准号:2186664
-
项目类别:
-
资助金额:$24.75万
-
财政年份:1994
-
负责人:RICHARD M MORTENSEN
-
依托单位:
GENETIC ANALYSIS OF G-PROTEIN FUNCTION
-
批准号:2022713
-
项目类别:
-
资助金额:$26.77万
-
财政年份:1994
-
负责人:RICHARD M MORTENSEN
-
依托单位:
STRUCTURE-FUNCTION ANALYSIS OF G PROTEIN SUBUNITS
-
批准号:2186665
-
项目类别:
-
资助金额:$25.74万
-
财政年份:1994
-
负责人:RICHARD M MORTENSEN
-
依托单位:
STRUCTURE-FUNCTION ANALYSIS OF G PROTEIN SUBUNITS
-
批准号:2186663
-
项目类别:
-
资助金额:$24.3万
-
财政年份:1994
-
负责人:RICHARD M MORTENSEN
-
依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
-
批准号:32000851
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:乔安娜
-
依托单位: